We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FTC Detects Cancer Screening Monopoly

Law360 (July 7, 2006, 12:00 AM EDT) -- The Federal Trade Commission filed a complaint Friday against Hologic Inc., saying the medical device maker’s $32 million purchase of rival Fischer Imaging Corp.’s breast cancer screening business would harm consumers by eliminating the only significant competition.

However, the FTC also filed a consent decree along with the suit, meaning the charges were dropped after Hologic agreed to sell its assets related to prone stereotactic breast biopsy systems to Siemens AG within the next five days.

Siemens, a medical imaging company, is well positioned to manufacture...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.